Journal Article > CommentaryFull Text
Lancet Diabetes Endocrinol. 1 December 2024; Online ahead of print; DOI: 10.1016/S2213-8587(24)00375-9
Jobanputra K, Fabreau G, Ansbro É
Lancet Diabetes Endocrinol. 1 December 2024; Online ahead of print; DOI: 10.1016/S2213-8587(24)00375-9
Journal Article > CommentaryFull Text
Lancet Diabetes Endocrinol. 1 March 2023; Volume 11 (Issue 3); 146-149.; DOI:10.1016/S2213-8587(23)00033-5
Kehlenbrink S, Jobanputra K, International Alliance for Diabetes Action
Lancet Diabetes Endocrinol. 1 March 2023; Volume 11 (Issue 3); 146-149.; DOI:10.1016/S2213-8587(23)00033-5
Journal Article > CommentaryFull Text
Lancet Diabetes Endocrinol. 1 February 2020; Volume 8 (Issue 2); DOI:10.1016/S2213-8587(19)30408-5
Kehlenbrink S, Boulle P
Lancet Diabetes Endocrinol. 1 February 2020; Volume 8 (Issue 2); DOI:10.1016/S2213-8587(19)30408-5
Journal Article > LetterFull Text
Lancet Diabetes Endocrinol. 7 February 2022; Volume S2213-8587 (Issue 22); 00036-5.; DOI:10.1016/S2213-8587(22)00036-5
Kehlenbrink S, Mahboob O, Al-Zubi S, Boulle P, Aebischer-Perone S, et al.
Lancet Diabetes Endocrinol. 7 February 2022; Volume S2213-8587 (Issue 22); 00036-5.; DOI:10.1016/S2213-8587(22)00036-5
Journal Article > CommentaryFull Text
Lancet Diabetes Endocrinol. 1 August 2019; DOI:10.1016/S2213-8587(19)30197-4.
Kehlenbrink S, Jaacks LM, Perone SA, Ansbro É, Ashbourne E, et al.
Lancet Diabetes Endocrinol. 1 August 2019; DOI:10.1016/S2213-8587(19)30197-4.
Journal Article > ReviewFull Text
Lancet Diabetes Endocrinol. 1 August 2019; Volume 7 (Issue 8); 648-656.; DOI:10.1016/S2213-8587(19)30083-X
Boulle P, Kehlenbrink S, Smith JS, Beran D, Jobanputra K
Lancet Diabetes Endocrinol. 1 August 2019; Volume 7 (Issue 8); 648-656.; DOI:10.1016/S2213-8587(19)30083-X
The humanitarian health landscape is gradually changing, partly as a result of the shift in global epidemiological trends and the rise of non-communicable diseases, including diabetes. Humanitarian actors are progressively incorporating care for diabetes into emergency medical response, but challenges abound. This Series paper discusses contemporary practical challenges associated with diabetes care in humanitarian contexts in low-income and middle-income countries, using the six building blocks of health systems described by WHO (information and research, service delivery, health workforce, medical products and technologies, governance, and financing) as a framework. Challenges include the scarcity of evidence on the management of diabetes and clinical guidelines adapted to humanitarian contexts; unavailability of core indicators for surveillance and monitoring systems; and restricted access to the medicines and diagnostics necessary for adequate clinical care. Policy and system frameworks do not routinely include diabetes and little funding is allocated for diabetes care in humanitarian crises. Humanitarian organisations are increasingly gaining experience delivering diabetes care, and interagency collaboration to coordinate, improve data collection, and analyse available programmes is in progress. However, the needs around all six WHO health system building blocks are immense, and much work needs to be done to improve diabetes care for crisis-affected populations.
Journal Article > ReviewFull Text
Lancet Diabetes Endocrinol. 13 March 2019; Volume 7 (Issue 8); 638-647.; DOI:10.1016/S2213-8587(19)30082-8
Kehlenbrink S, Smith JS, Ansbro É, Fuhr D, Cheung ATL, et al.
Lancet Diabetes Endocrinol. 13 March 2019; Volume 7 (Issue 8); 638-647.; DOI:10.1016/S2213-8587(19)30082-8
Human suffering as a result of natural disasters or conflict includes death and disability from non-communicable diseases, including diabetes, which have largely been neglected in humanitarian crises. The objectives of this Series paper were to examine the evidence on the burden of diabetes, use of health services, and access to care for people with diabetes among populations affected by humanitarian crises in low-income and middle-income countries, and to identify research gaps for future studies. We reviewed the scientific literature on this topic published between 1992 and 2018. The results emphasise that the burden of diabetes in humanitarian settings is not being captured, clinical guidance is insufficient, and diabetes is not being adequately addressed. Crisis-affected populations with diabetes face enormous constraints accessing care, mainly because of high medical costs. Further research is needed to characterise the epidemiology of diabetes in humanitarian settings and to develop simplified, cost-effective models of care to improve the delivery of diabetes care during humanitarian crises.
Journal Article > LetterFull Text
Lancet Diabetes Endocrinol. 1 January 2022; Volume 10 (Issue 1); 20-21.; DOI:10.1016/S2213-8587(21)00320-X
Reddy A
Lancet Diabetes Endocrinol. 1 January 2022; Volume 10 (Issue 1); 20-21.; DOI:10.1016/S2213-8587(21)00320-X
Journal Article > LetterFull Text
Lancet Diabetes Endocrinol. 25 March 2022; Volume S2213-8587 (Issue 22); 00105-X.; DOI:10.1016/S2213-8587(22)00105-X
Maystruk G, Aebischer-Perone S, Anufriyeva V, Boulle P, Chappuis F, et al.
Lancet Diabetes Endocrinol. 25 March 2022; Volume S2213-8587 (Issue 22); 00105-X.; DOI:10.1016/S2213-8587(22)00105-X